Riskpilot← Back to searchSign inGet full accessNordic Biomarker Holding AB
ABActiveOrg 5593656621Vildmannavägen 1Activities of head offices · NACE 7010Est. 20220 employees
Revenue 2024
SEK 342K
-1% vs 2023
EBITDA margin
-238.6%
-56% vs 2023
Equity ratio
62.0%
Financial strength
Net profit 2024
SEK 74,8M
+112% vs 2023
| Revenue | SEK 342K | -1% |
| EBITDA | SEK -816K | -56% |
| Net profit | SEK 74,8M | +112% |
| Total assets | SEK 150,4M | +470% |
| Equity | SEK 93,3M | +159% |
| Employees | 0 | — |
Legal name
Nordic Biomarker Holding AB
Org number
5593656621
Legal form
Aktiebolag
NACE code
7010 · Activities of head offices
Founded
15 februari 2022
Share capital
SEK 99 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med en av Conradsson, Johan Fredrik Kristiansson, Erik Richard Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolagets verksamhetsföremål är att äga dotterbolag och att tillhandahålla konsulttjänster avseende strategi, ledarskap, affärsutveckling och administration till koncernbolag, att direkt eller indirekt äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Vildmannavägen 1
Email
eva.isaksson@nordicbiomarker.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 237 | 344 | 342 |
| Staff expenses | — | — | — |
| EBITDA | −322 | −522 | −816 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | −322 | −522 | −816 |
| Net financials | 12 | −624 725 | 75 593 |
| Profit before tax | −310 | −625 247 | 74 777 |
| Tax | −0 | −0 | −0 |
| Net profit | −310 | −625 247 | 74 777 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 452 999 | 26 377 | 150 395 |
| Equity | 452 670 | −157 274 | 93 252 |
| Long-term debt | 0 | 183 174 | 52 771 |
| Short-term debt | 329 | 477 | 4 372 |
| Total debt | 329 | 183 651 | 57 143 |
EBITDA margin
-238.6%
This company
15.8%
Market median
-1610% vs market
20222024
Equity ratio
62.0%
This company
38.2%
Market median
+62% vs market
20222024
Return on equity
80.2%
This company
18.4%
Market median
+336% vs market
20222024
Net profit margin
21864.6%
This company
8.1%
Market median
+269833% vs market
20222024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20222024
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RA Chief Executive Officer | Chief Executive Officer | 2022 |
JA Chief Auditor | Chief Auditor | 2022 |
| Former (1) | ||
JM Chief Auditor | Chief Auditor | 2023 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Chairman | 2026 | |
| Board of Directors | 2022 | |
| Former (19) | ||
| Chairman | 2023 – 2023 | |
| Chairman | 2025 – 2026 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2023 – 2023 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2023 – 2026 | |
| Board of Directors | 2022 – 2026 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nordic Biomarker Holding AB 
Nordic Biomarker Bidco ABBoard members of Nordic Biomarker Holding AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johanna Margareta Eklöf | Chief Auditor | 0 companies |
| Rikard Albert Rodén | Chief Executive Officer | 0 companies |
| Johan Anders Pettersson | Chief Auditor | 0 companies |
| Björn Rolf Nordenvall | Chairman | 0 companies |
| Johan Olof Tade von Heijne | Chairman | 0 companies |
| Hans Jarl Rutger Arnhult | Deputy Board Member | 0 companies |
| Bo Daniel Falk | Deputy Board Member | 0 companies |
| Viktor Elias Bergman Gullmark | Deputy Board Member | 0 companies |
| Emma Maria Birgitta Wik | Deputy Board Member | 0 companies |
| Cecilia Linnea Waldehorn | Board of Directors | 0 companies |
| Andreas Hans Eddie Ottosson | Deputy Board Member | 0 companies |
| Anna Matilda Sjödin | Deputy Board Member | 0 companies |
| Lars Anders Larsson | Board of Directors | 0 companies |
| Petra Waltraud Wester | Board of Directors | 0 companies |
| Göran Aronsson | Board of Directors | 0 companies |
| Bill Tunbrant | Board of Directors | 0 companies |
| Anna Carolina Maria Bjarnhagen | Deputy Board Member | 0 companies |
| Peter Richard Schmid | Board of Directors | 0 companies |
| Claes Gustav Tyko Blanche | Board of Directors | 0 companies |
| Johan Fredrik Conradsson | Chairman | 0 companies |
| Rolf Stefan Janse | Deputy Board Member | 0 companies |
| Eva Evelina Evelyn Sjöstedt | Deputy Board Member | 0 companies |
| Mari Sinikka Kovaniemi Feldt | Deputy Board Member | 0 companies |
| Olina Kristina Maria Wåhlstedt | Deputy Board Member | 0 companies |
| Erik Richard Kristiansson | Board of Directors | 0 companies |